Spirooxindole 5‐(Trifluoromethyl)benzothiazole Hybrids: Synthesis, Crystal Structure, and Antioxidant Activity
Archiv der Pharmazie · 2026
DOI: 10.1002/ardp.70343 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2026. Verfasst von Nida Karabag und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Antioxidants, Benzothiazoles, Spirooxindoles. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Istanbul University Scientific Research Projects.
Abstract (Originalsprache)
Antioxidants neutralize free radicals to reduce oxidative stress and cellular damage, preventing various chronic diseases. In this study, the antioxidant activities of novel 5‐(trifluoromethyl)‐3 H ‐spiro[1,3‐benzothiazole‐2,3′‐indol]‐2′(1′ H )‐ones ( 4a–h ), along with the spirocyclic 2‐indolinones ( 4i–m and 5a–n ) previously synthesized by our group, were investigated for the first time, to find a multi‐modal antioxidant and to understand the impact of the trifluoromethyl group located at the 5‐position of the benzothiazole on antioxidant activity. For this purpose, the 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH•) free radical scavenging, superoxide anion scavenging, ABTS •+ radical cation scavenging, trolox equivalent antioxidant capacity, ferric ion reduction antioxidant potential (FRAP), and lipid peroxidation (TBARs) assays were carried out. The cytotoxic effects of compounds ( 4g , 4h , 4i , 4j , 4l , 5a , 5b , and 5h) , which showed promising in vitro antioxidant activity in at least two in vitro tests, were investigated in healthy human fibroblast (HFF‐1) cells. The effects of non‐toxic doses of these compounds on intracellular reactive oxygen species were also evaluated. As a result, it was determined that compound 4l (R 1 = 5‐F and R 2 = H) exhibited greater radical scavenging activity than the other compounds tested. The IC 50 of compound 4l was 74.13 µM while compound 4g (R 1 = 5‐Cl‐7‐CH 3 and R 2 = H) was non‐toxic (IC 50 > 200 μM). Compounds 4e (R 1 = 5‐Cl and R 2 = H) and 4f (R 1 = 7‐Br and R 2 = H), exhibited higher lipid peroxidation inhibitory activity than α‐tocopherol in vitro; however, the difference was not statistically significant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey.
- Department of Pharmaceutical Chemistry, Institute of Health Sciences, Istanbul University, Istanbul, Turkey.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Istanbul University-Cerrahpaşa, Istanbul, Turkey.
- Department of Molecular Biology and Genetics, Faculty of Science, Istanbul University, Istanbul, Turkey.
- Department of Physical Engineering, Faculty of Engineering, Hacettepe University, Ankara, Turkey.
- Department of Biochemistry, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey.
ORCID-Profile: Asu Busra Temizer-Keser, Murat Pekmez, Elif Mertoğlu-Kamalı, Nazlı Arda, Nilgün Karalı
Förderung
- Istanbul University Scientific Research Projects
Zitieren
APA
Karabag, N., Temizer-Keser, A. B., Pekmez, M., Mertoğlu-Kamalı, E., Kaynak, F. B., Özsoy, N., Arda, N., & Karalı, N. (2026). Spirooxindole 5‐(Trifluoromethyl)benzothiazole Hybrids: Synthesis, Crystal Structure, and Antioxidant Activity. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70343
Vancouver
Karabag N, Temizer-Keser AB, Pekmez M, Mertoğlu-Kamalı E, Kaynak FB, Özsoy N, et al. Spirooxindole 5‐(Trifluoromethyl)benzothiazole Hybrids: Synthesis, Crystal Structure, and Antioxidant Activity. Archiv der Pharmazie. 2026. doi:10.1002/ardp.70343
BibTeX
@article{Karabag2026,
author = {Karabag, Nida and Temizer-Keser, Asu Busra and Pekmez, Murat and Mertoğlu-Kamalı, Elif and Kaynak, Filiz Betül and Özsoy, Nurten and Arda, Nazlı and Karalı, Nilgün},
title = {Spirooxindole 5‐(Trifluoromethyl)benzothiazole Hybrids: Synthesis, Crystal Structure, and Antioxidant Activity},
journal = {Archiv der Pharmazie},
year = {2026},
doi = {10.1002/ardp.70343}
}
EUVIMED